No. AR PL HD Year Citation Title 1st author
75 X 2020 Blood Adv 4 (21): 5501-5511(2020) Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system Y Suzuki
73 X 2020 Int J Cardiol S0167-5273(20),p33924-33933(2020) Development and assessment of total thrombus-formation analysis system-based bleeding risk model in patients undergoing percutaneous coronary intervention N Nakanishi
72 X X 2020 Pol Arch Intern Med(2020) Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome? K Ożegowska
70 X 2020 PLoS ONE 15(10): e0237843(2020) Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus M Osiński
69 X X 2020 Pediatr Int (2020) A microchip flow-chamber assay screens congenital primary hemostasis disorders Y Nakajima
68 X 2020 Thromb Res 194,p98-100(2020) Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit A Ågren
67 X X 2020 Kardiol Pol 78(7-8),p667-673(2020) New methodological approaches for assessing thrombus formation in cardiovascular disease K Hosokawa
64 X 2020 Int J Mol Sci 21(11),3972(2020) E8002 Inhibits Peripheral Nerve Adhesion by Enhancing Fibrinolysis of l-Ascorbic Acid in a Rat Sciatic Nerve Model K Kikuchi
62 X X 2020 Front Vet Sci 7:307(2020) A Novel Microchip Flow Chamber (Total Thrombus Analysis System) to Assess Canine Hemostasis T Iwanaga
61 X 2020 In Vivo 34(4),p1871-1874(2020) Association Between HMGB1 and Thrombogenesis in a Hyperlipaemia-induced Microminipig Model of Atherosclerosis S Kase
60 X X 2020 Circ J 84(6),p975-984(2020) Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention S Kikuchi
58 X X 2019 Int J Hematol 111, p369-377(2020) Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system Y Nakajima
57 X X 2019 J Atheroscler Thromb 27(3),p201-203(2020) Monitoring of Antithrombotic Therapy M Yamazaki
56 X X 2019 Thromb J 17, 17 (2019) Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study observational study K Yamamoto
55 X X 2019 J Atheroscler Thromb 27,p215-225(2020) Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease T Mitsuse
54 X X 2019 Thromb Haemost 119,p1554-1562(2019) Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease K Kaikita
53 X X 2019 Sci Rep 9:6573(2019) Sulfenamide and Sulfonamide Derivatives of Metformin – A New Option to Improve Endothelial Function and Plasma Haemostasis MM Piasecka
52 X X 2019 Circ J 83(6),p1309-1316(2019) Impact of Total Antithrombotic Effect on Bleeding Complications in Patients Receiving Multiple Antithrombotic Agents S Ichikawa
51 X 2019 Int J Cardiol Heart Vasc 23:100346(2019) Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation – The ATTRACTIVE-TTAS study M Ishii
50 X X 2019 Clin Exp Thromb Hemost 5(1),p1-7(2019) Effects of Peroxisome Proliferator-Activated Receptor Ligand and Brown Seaweed Based Compound on Megakaryocyte JL Choi
PL Chip for T-TAS01 is available for in vitro diagnostic use only in the the United States and EU Copyright © 2021 FUJIMORI KOGYO CO.,LTD. All Rights Reserved.